U.S. flag

An official website of the United States government

NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp) AND Biotinidase deficiency

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 19, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002664296.5

Allele description [Variation Report for NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)]

NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)

Gene:
BTD:biotinidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.1
Genomic location:
Preferred name:
NM_001370658.1(BTD):c.1292G>A (p.Gly431Asp)
HGVS:
  • NC_000003.12:g.15645208G>A
  • NG_008019.2:g.48857G>A
  • NG_008019.3:g.48858G>A
  • NM_000060.4:c.1352G>A
  • NM_001281723.4:c.1292G>A
  • NM_001281724.3:c.1292G>A
  • NM_001281725.3:c.1292G>A
  • NM_001323582.2:c.1292G>A
  • NM_001370658.1:c.1292G>AMANE SELECT
  • NM_001370752.1:c.1015+277G>A
  • NM_001370753.1:c.399+3151G>A
  • NM_001407364.1:c.1292G>A
  • NM_001407365.1:c.1292G>A
  • NM_001407366.1:c.1292G>A
  • NM_001407367.1:c.1292G>A
  • NM_001407368.1:c.1292G>A
  • NM_001407369.1:c.1292G>A
  • NM_001407370.1:c.1292G>A
  • NM_001407371.1:c.1292G>A
  • NM_001407372.1:c.1292G>A
  • NM_001407373.1:c.1292G>A
  • NM_001407374.1:c.1292G>A
  • NM_001407375.1:c.1292G>A
  • NM_001407376.1:c.1292G>A
  • NM_001407377.1:c.1292G>A
  • NM_001407378.1:c.1292G>A
  • NP_000051.1:p.Gly451Asp
  • NP_001268652.2:p.Gly431Asp
  • NP_001268652.2:p.Gly431Asp
  • NP_001268653.2:p.Gly431Asp
  • NP_001268654.1:p.Gly431Asp
  • NP_001268654.1:p.Gly431Asp
  • NP_001310511.1:p.Gly431Asp
  • NP_001310511.1:p.Gly431Asp
  • NP_001357587.1:p.Gly431Asp
  • NP_001394293.1:p.Gly431Asp
  • NP_001394294.1:p.Gly431Asp
  • NP_001394295.1:p.Gly431Asp
  • NP_001394296.1:p.Gly431Asp
  • NP_001394297.1:p.Gly431Asp
  • NP_001394298.1:p.Gly431Asp
  • NP_001394299.1:p.Gly431Asp
  • NP_001394300.1:p.Gly431Asp
  • NP_001394301.1:p.Gly431Asp
  • NP_001394302.1:p.Gly431Asp
  • NP_001394303.1:p.Gly431Asp
  • NP_001394304.1:p.Gly431Asp
  • NP_001394305.1:p.Gly431Asp
  • NP_001394306.1:p.Gly431Asp
  • NP_001394307.1:p.Gly431Asp
  • NC_000003.11:g.15686715G>A
  • NM_001281723.3:c.1292G>A
  • NM_001281725.2:c.1292G>A
  • NM_001323582.1:c.1292G>A
  • P43251:p.Gly451Asp
Protein change:
G431D
Links:
UniProtKB: P43251#VAR_005118; dbSNP: rs397514419
NCBI 1000 Genomes Browser:
rs397514419
Molecular consequence:
  • NM_001370752.1:c.1015+277G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001370753.1:c.399+3151G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000060.4:c.1352G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281723.4:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281724.3:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281725.3:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323582.2:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370658.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407364.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407365.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407366.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407367.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407368.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407369.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407370.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407371.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407372.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407373.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407374.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407375.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407376.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407377.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407378.1:c.1292G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Biotinidase deficiency
Synonyms:
BTD deficiency; Late-onset biotin-responsive multiple carboxylase deficiency; Biotin deficiency
Identifiers:
MONDO: MONDO:0009665; MedGen: C0220754; Orphanet: 79241; OMIM: 253260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003525318Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Aug 19, 2022)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene.

Swango KL, Demirkol M, Hüner G, Pronicka E, Sykut-Cegielska J, Schulze A, Mayatepek E, Wolf B.

Hum Genet. 1998 May;102(5):571-5. Erratum in: Hum Genet 1998 Jun;102(6):712.

PubMed [citation]
PMID:
9654207

Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007-2014).

Gannavarapu S, Prasad C, DiRaimo J, Napier M, Goobie S, Potter M, Chakraborty P, Karaceper M, Munoz T, Schulze A, MacKenzie J, Li L, Geraghty MT, Al-Dirbashi OY, Rupar CA.

Mol Genet Metab. 2015 Nov;116(3):146-51. doi: 10.1016/j.ymgme.2015.08.010. Epub 2015 Aug 31.

PubMed [citation]
PMID:
26361991
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003525318.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This missense change has been observed in individual(s) with clinical features of biotinidase deficiency (PMID: 9654207, 26361991). This variant is present in population databases (rs397514419, gnomAD 0.006%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 451 of the BTD protein (p.Gly451Asp).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024